Article No.4
Regular
Phytoestrogen Consumption Reduces Endometrial Cancer Risk
Reuters Health Aug 14 - Regular consumption of estrogens found in plant foods
may reduce the risk of endometrial cancer for some women, according to a report
in the August 6th Journal of the National Cancer Institute.
Estrogen exposure without cyclic
exposure to progesterone contributes to the development of endometrial cancer,
the authors explain, and phytoestrogens have been shown to lower endogenous
estrogen levels.
Dr. Pamela L. Horn-Ross from Northern
California Cancer Center in Union City, California, and colleagues conducted
the first analytic epidemiologic study that has quantified the intake of specific
phytoestrogenic compounds and related them to endometrial cancer risk.
The top quartiles of consumption
of total isoflavones and of total lignans were associated with a 41% and 32%
reduced risk, respectively, of endometrial cancer, compared with the lowest
quartiles of consumption, the authors report.
Specifically, the reduced risk of
endometrial cancer was associated with higher levels of consumption of the two
major isoflavones -- genistein and daidzein -- and of the lignan secoisolariciresinol,
the report indicates.
The reduced endometrial cancer risk
was particularly evident among postmenopausal women who consumed high levels
of isoflavones and lignans, the researchers note.
Though the number of obese women
in the study was small, the results suggest that obese postmenopausal women
consuming the lowest levels of isoflavones or lignans had the highest risk of
endometrial cancer.
"Based on these findings and
other literature on phytoestrogens, I believe that recommending a balanced diet
that includes reasonable amounts of phytoestrogen-rich foods is an appropriate
public health message at this time," Dr. Horn-Ross told Reuters Health.
"In my opinion, however, we don't have enough information on phytoestrogen
supplements in pill form to make any recommendations in either direction regarding
these supplements."
Dr. Horn-Ross cautioned, "There
is a lot of variability between people, and benefit (or harm) from a given exposure
is unlikely to apply across the board. We are working on furthering our understanding
of the relationships between phytoestrogens and cancer risk."
"In the meantime," she
concluded, "it appears that soy-based and lignan-rich foods may have beneficial
effects in some women, with some evidence that it will be greater in postmenopausal
women and overweight/obese women. However, we still have much to learn."
J Natl Cancer Inst 2003;95:1158-1164.
Back
Next